A Study of LY4515100 in Participants With Pain Following Third Molar Removal

NCT07511816 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

212

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Pain
Molar
Molar, Third
Surgery, Oral

Interventions

DRUG: LY4515100
DRUG: Placebo

Sponsor

Eli Lilly and Company